CIBC WORLD MARKET INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC WORLD MARKET INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,548
-100.0%
27,214
-75.4%
0.01%
-66.7%
Q4 2020$4,733,000110,8280.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders